Dr. Elbuluk discusses a recently published retrospective chart review that she and her colleagues published in the Archives of Dermatological Research, which included all patients diagnosed with vitiligo treated at a private hospital and a public hospital over a period of ten years, with a focus on associated psychiatric comorbidities. She summarizes the findings of rates of anxiety and depression in patients with vitiligo in terms of gender, race, and socioeconomic status.
Andrea Nguyen discusses how she counsels patients with vitiligo and emphasizes the importance in communicating with patients about consistent application and dosing during a treatment regimen.
Dr. Watchmaker discusses her own experience using a novel serum (Mystro Active Balance Serum; Skinbetter Science) in patients looking to improve erythema and their post-procedure regimen.
Dr. Watchmaker reviews a multi-center study that evaluated the ability of a novel serum (Mystro Active Balance Serum; Skinbetter Science) to improve the overall quality of the skin.
Dr. Watchmaker reviews encouraging results from a clinical study that evaluated the compatibility of a novel serum (Mystro Active Balance Serum; Skinbetter Science) for use with patients undergoing non-ablative fractional laser treatments and medium depth chemical peels.